Bivalirudin 250 mg inj

Bivalirudin 250 mg inj
Product Description

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bivalirudin 250 mg inj. It belongs to cardiac finish formulations products category. Contact us for more information.

Read more Show less

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    International Approvals/Standards
  • Supplied from
    India
More specifications Fewer specifications

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile

More Products from BDR PHARMACEUTICALS INTERNATIONAL PVT. (99)

  • Biapenem 300 mg / 600 mg* --- under development

    Product Biapenem 300 mg / 600 mg* --- under development

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes biapenem 300 mg / 600 mg* --- under development. It belobgs to carbapenem finish formulations products category. Contact us for more information.
  • Biapenem*

    Product Biapenem*

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes biapenem*. It belongs to antibacterial ( betalactum ) apis products category. Contact us for more information.
  • Bicalutamide

    Product Bicalutamide

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bicalutamide. It belongs to antineoplastic apis category. Contact us for more information.
  • Bicalutamide tablets 50 mg

    Product Bicalutamide tablets 50 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bicalutamide tablets 50 mg. It belongs toanticancer ( oral / injection) finish formulations products category. Contact us for more information.
  • Bimatoprost

    Product Bimatoprost

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bimatoprost. It belongs to antiglaucoma apis products category. Contact us for more information.
  • Bivalirudin

    Product Bivalirudin

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bivalirudin. It belongs to anticoagulant apis category. Contact us for more information.
  • Bleomycin sulphate 15 mg

    Product Bleomycin sulphate 15 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bleomycin sulphate 15 mg. It belongs toalyophilised injections finish formulations products category. Contact us for more information.
  • Bortezomib

    Product Bortezomib

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bortezomib. It belongs to antineoplastic apis category. Contact us for more information.
  • Bortezomib 2 mg/ 3.5 mg

    Product Bortezomib 2 mg/ 3.5 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes bortezomib 2 mg/ 3.5 mg. It belongs toalyophilised injections finish formulations products category. Contact us for more information.
  • Brinzolamide

    Product Brinzolamide

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes brinzolamide. It belongs to antiglaucoma apis products category. Contact us for more information.
  • Buserelin acetate

    Product Buserelin acetate

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes buserelin acetate. It belongs to infertility apis category. Contact us for more information.
  • Buserelin acetate injection (7 mg / 7 ml)

    Product Buserelin acetate injection (7 mg / 7 ml)

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes buserelin acetate injection (7 mg / 7 ml). It belongs to gynaecology finish formulations products category. Contact us for more information.
show all 99 other products

BDR PHARMACEUTICALS INTERNATIONAL PVT. resources (1)